Abstract

Graves disease is an autoimmune disorder affecting the thyroid gland with a wide range of clinical manifestations. One of the most notable signs of Graves disease is hyperthyroidism. In general, there are three options in treating Graves hyperthyroidism: pharmacological therapy, thyroidectomy, and radioactive iodine therapy. Thionamides, which consist of methimazole, carbimazole, and propylthiouracil, are considered to be the most prominent pharmacological therapy of Graves disease. Among these drugs, propylthiouracil is the least favored because of its adverse effects.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.